Designing a global monitoring system for pilot introduction of a new contraceptive technology, subcutaneous DMPA (DMPA-SC)

Autor: Anna Stout, Daouda Siddo, Allen Namagembe, Siri Wood, Alain Kaboré, Ida Ndione
Rok vydání: 2017
Předmět:
Process management
Strategy and Management
Data management
Geography
Planning and Development

Product introduction
Pilot Projects
0302 clinical medicine
Information system
Contraceptive Agents
Female

Uganda
030212 general & internal medicine
Niger
Program Development
030219 obstetrics & reproductive medicine
Injectable contraception
Stakeholder
Pilot
Health information systems (HIS)
Senegal
Product (business)
Family planning
DMPA-SC
Adult
Capacity Building
Social Psychology
Adolescent
Injections
Subcutaneous

Developing country
Medroxyprogesterone Acetate
Article
03 medical and health sciences
Young Adult
Chart
Burkina Faso
Humans
Indicators
Sayana Press
Business and International Management
Africa South of the Sahara
Contraceptive introduction
Monitoring systems
Data collection
business.industry
Public Health
Environmental and Occupational Health

Delayed-Action Preparations
Africa
Subcutaneous DMPA
Business
Program Evaluation
Zdroj: Evaluation and Program Planning
ISSN: 1873-7870
Popis: Highlights • From 2014 to 2016, the MOHs of Burkina Faso, Niger, Senegal and Uganda launched pilot introductions of the novel injectable contraceptive DMPA-SC. • This manuscript describes a four-phase approach to monitoring DMPA-SC pilot introduction across the four countries. • Existing national family planning registers were used to monitor DMPA-SC pilot introductions, with modifications. • Comprehensive data from DMPA-SC pilot introduction informed decisions about future investments in the product and scaling product availability nationally.
In collaboration with ministries of health, PATH and key partners launched the first pilot introductions of subcutaneous depot medroxyprogesterone acetate (DMPA-SC, brand name Sayana® Press) in Burkina Faso, Niger, Senegal, and Uganda from July 2014 through June 2016. While each country implemented a unique introduction strategy, all agreed to track a set of uniform indicators to chart the effect of introducing this new method across settings. Existing national health information systems (HIS) were unable to track new methods or delivery channels introduced for a pilot, thus were not a feasible source for project data. We successfully monitored the four-country pilot introductions by implementing a four-phase approach: 1) developing and defining global indicators, 2) integrating indicators into existing country data collection tools, 3) facilitating consistent reporting and data management, and 4) analyzing and interpreting data and sharing results. Project partners leveraged existing family planning registers to the extent possible, and introduced new or modified data collection and reporting tools to generate project-specific data where necessary. We routinely shared monitoring results with global and national stakeholders, informing decisions about future investments in the product and scale up of DMPA-SC nationwide. Our process and lessons learned may provide insights for countries planning to introduce DMPA-SC or other new contraceptive methods in settings where stakeholder expectations for measureable results for decision-making are high.
Databáze: OpenAIRE